Skip to main content

Factors ID'd for Clean Intermittent Catheterization Compliance in Youth With Neurogenic Bladder

Medically reviewed by Carmen Pope, BPharm. Last updated on May 8, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, May 8, 2024 -- For children with neurogenic bladder, self-catheterization is associated with lower adherence to clean intermittent catheterization (CIC), according to a study recently published in the Journal of Pediatric Urology.

Simran K. Sidhu, from Kuala Lumpur Hospital in Malaysia, and colleagues identified factors that could affect CIC compliance and examined the association between CIC compliance and short-term urological outcomes in children with neurogenic bladder due to spina bifida and caudal regression syndrome. The validated Intermittent Catheterization Adherence Scale was used to assess patient compliance with CIC among 50 patients aged 2 to 18 years. The validated Intermittent Catheterization Difficulty Questionnaire (ICDQ) was used to assess CIC difficulties.

The researchers found that 60 percent of the participants showed strong adherence to CIC. Most (78 percent) were able to catheterize with no or minor difficulties; the main difficulties encountered were pain, transient blocking sensation, and urinary incontinence (12, 12, and 6 percent, respectively). Adherence was improved with CIC performed by caregiver versus patient self-catheterization. Patients who purchased their own CIC catheters also had strong adherence. The likelihood of being compliant with CIC was higher for patients with a lower ICDQ score. Patient's age, gender, comorbidity, mobility, caregiver factors, socioeconomic factors, and age at initiation of CIC did not affect CIC adherence. No significant association was seen between CIC adherence and febrile urinary tract infections, upper tract deterioration, and bladder stones at follow-up of six months.

"Our study provides insights on facilitators and barriers to instituting CIC that will improve care and counseling provided to patients," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2024

Read this next

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care

TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.